Priority Date: 06.12.12 (US 201261734135P)

TREATMENT OF INFLAMMATION, AUTOIMMUNE, AND NEURODEGENERATIVE DISORDERS WITH IMMUNOSUPPRESSIVE TAT DERIVATIVE POLYPEPTIDES

  • Application ID: EP13860686
  • Status: GRANT OF PATENT INTENDED

Attorney

no operation time available
8 offices
active in Legal Services

Specialization

This EP application has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY). We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 233 others are specialized in this combination either. For a similar patent, they might be a good choice.

Timeline

  • 06.12.2012 - Priority Date (US 201261734135P)
  • 12.06.2014 - Publication A1 (WO2014089480)
  • 14.10.2015 - Publication A1 (EP2928910)

IPC Classification